Uracil C-13

DB16345InvestigationalSmall molecule

Uracil C-13 is under investigation in clinical trial NCT01677338 (Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects).

Chemical structure of Uracil C-13
Formula / weight
C4H4N2O2 · 113.08 g/mol (avg)
Also known as
13C-uracil · Uracil (2-13c) · Uracil 2c-13 · Uracil C-13, 2- · Uracil-(2-13c)

Resolves to

Compound
UNIIOZF8J4VAIKCAS35803-45-3
Structure
InChIKeyISAKRJDGNUQOIC-AZXPZELESA-NSMILESO=C1N[13C](=O)NC=C1

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Uracil C-13, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In